Protease inhibitors.
D000998:Antiviral Agents / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D019259:Lamivudine; D016047:Zalcitabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D016047:Zalcitabine